Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.
about
Modulatory effects of bortezomib on host immune cell functionsIFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisInvestigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria.Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Productively combining proteasome inhibition with the immunotherapy of cancer.Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibodyProteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.Pharmacotherapy of neuroblastoma.Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation.Characterization of the protein ubiquitination response induced by Doxorubicin.Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link.Powerful inner/outer controlled multi-target magnetic nanoparticle drug carrier prepared by liquid photo-immobilization.The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp.Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance.
P2860
Q26795618-DE10270A-218E-43BE-82C9-AA3872ABAECAQ34598755-E18C5385-6D77-49C2-B74D-D05B77A319E1Q34700759-2C0EEDA6-B1ED-465F-ACDC-245A7C96177BQ35863135-598BD075-DC34-4A0C-B49F-F26975B34642Q36378038-063D0FD8-B9F8-43B6-A9D1-A39291B6C722Q37301320-EF591CF9-F350-4655-9FC5-92123E61C030Q37348050-883F5727-7CF8-4FF8-86B4-8962524C352EQ37367298-AD102ECA-0609-4463-9985-373DF3D93007Q37390575-A29B0F54-7858-47C0-8D9A-5B11157FDB96Q37689041-9E8FB223-24C0-4679-8E11-A565CB85E9A0Q37702765-9CC9EC13-2775-44EE-B69E-00F3E678E0A0Q37735199-090FA1FB-BA06-4E2F-86F0-30E7E6A64FCEQ39058933-2AAF4615-54DC-4528-9568-2FCF90CF449BQ39358271-6A2B95C9-EE56-45DA-8577-9F01F4FBF1D9Q39500830-4B3F6F77-AB12-46C4-AC11-EB71AC3FC23FQ39818289-65045FC9-7DA3-435D-BCC6-7E629F53F74FQ39873607-3A406A20-4381-4924-8359-1FDCCA225972Q42026439-7DB5C381-8CB8-44E6-A2BF-4DECBFE466E2Q42042886-5378F904-E4F7-47D2-A9EB-89781257098F
P2860
Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Proteasome inhibition to maxim ...... r murine neuroblastoma tumors.
@en
type
label
Proteasome inhibition to maxim ...... r murine neuroblastoma tumors.
@en
prefLabel
Proteasome inhibition to maxim ...... r murine neuroblastoma tumors.
@en
P2093
P1476
Proteasome inhibition to maxim ...... r murine neuroblastoma tumors.
@en
P2093
Alma C Arnold
Douglas Powell
Erin Lincoln
Jimmy K Stauffer
Jon M Wigginton
Julie A Hixon
Rebecca Williams
Rosalba Salcedo
Stephen Lockett
Tahira Khan
P304
P356
10.4049/JIMMUNOL.176.10.6302
P407
P577
2006-05-01T00:00:00Z